Insight into the Quality of Life of Patients with Ankylosing Spondylitis: Real-World Data from a US-Based Life Impact Survey

[1] Rudwaleit M(2009)The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part I): classification of paper patients by expert opinion including uncertainty appraisal Ann Rheum Dis 68 770-776

[2] Landewe R(2013)The epidemiology of back pain, axial spondyloarthritis and HLA-B27 in the United States Am J Med Sci 345 431-436

[3] van der Heijde D(2011)Spondyloarthritis Lancet 377 2127-2137

[4] Reveille JD(2010)Comorbidity profiles among patients with ankylosing spondylitis: a nationwide population-based study Ann Rheum Dis 69 1165-1168

[5] Weisman MH(2009)Ankylosing spondylitis patients commencing biologic therapy have high baseline levels of comorbidity: a report from the Australian Rheumatology Association database Int J Rheumatol 2009 268569-556

[6] Dougados M(2011)Population-based estimates of common comorbidities and cardiovascular disease in ankylosing spondylitis Arthritis Care Res (Hoboken) 63 550-631

[7] Baeten D(2016)Risk of psychiatric disorders following ankylosing spondylitis: a nationwide population-based retrospective cohort study J Rheumatol 43 625-1002

[8] Kang JH(2015)Uveitis in spondyloarthritis including psoriatic arthritis, ankylosing spondylitis, and inflammatory bowel disease Clin Rheumatol 34 999-298

[9] Chen YH(2016)American College of Rheumatology/Spondylitis Association of America/Spondyloarthritis Research and Treatment Network 2015 recommendations for the treatment of ankylosing spondylitis and nonradiographic axial spondyloarthritis Arthritis Rheumatol 68 282-991

[10] Lin HC(2017)2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis Ann Rheum Dis 76 978-438

[1] Rudwaleit M(2009)The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part I): classification of paper patients by expert opinion including uncertainty appraisal Ann Rheum Dis 68 770-776

[2] Landewe R(2013)The epidemiology of back pain, axial spondyloarthritis and HLA-B27 in the United States Am J Med Sci 345 431-436

[3] van der Heijde D(2011)Spondyloarthritis Lancet 377 2127-2137

[4] Reveille JD(2010)Comorbidity profiles among patients with ankylosing spondylitis: a nationwide population-based study Ann Rheum Dis 69 1165-1168

[5] Weisman MH(2009)Ankylosing spondylitis patients commencing biologic therapy have high baseline levels of comorbidity: a report from the Australian Rheumatology Association database Int J Rheumatol 2009 268569-556

[6] Dougados M(2011)Population-based estimates of common comorbidities and cardiovascular disease in ankylosing spondylitis Arthritis Care Res (Hoboken) 63 550-631

[7] Baeten D(2016)Risk of psychiatric disorders following ankylosing spondylitis: a nationwide population-based retrospective cohort study J Rheumatol 43 625-1002

[8] Kang JH(2015)Uveitis in spondyloarthritis including psoriatic arthritis, ankylosing spondylitis, and inflammatory bowel disease Clin Rheumatol 34 999-298

[9] Chen YH(2016)American College of Rheumatology/Spondylitis Association of America/Spondyloarthritis Research and Treatment Network 2015 recommendations for the treatment of ankylosing spondylitis and nonradiographic axial spondyloarthritis Arthritis Rheumatol 68 282-991

[10] Lin HC(2017)2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis Ann Rheum Dis 76 978-438